Security key
74275C304
Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PCSA)
CUSIP: 74275C304
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 48,551
- Total 13F value
- $66,515
- Share change
- +3,521
- SEC-reported price per share
- $1.37
- Number of holders
- 8
- Value change
- +$4,752
- Number of buys
- 4
- Number of sells
- 1
- Shares outstanding
- 2,857,143
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
8
Top holders
8
PCSA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Processa Pharmaceuticals, Inc. SEC filings
Processa Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74275C304
Recent filing periods:
Ownership snapshot
Top reported holders of PCSA - Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
James H. Stanker
Comparable rows
8/12
Latest evidence
30 Jun 2024
13F
3/4/5
Lead comparable stake: 0.86%
4 rows are not safely comparable across share classes.
Showing 1-6 of 12 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 0.86%.
8 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
0.86%
GEODE CAPITAL MANAGEMENT, LLC
0.6%
Tower Research Capital LLC (TRC)
0.1%
WELLS FARGO & COMPANY/MN
0.01%
Main Street Group, LTD
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
0.86%
|
$54,730
24,433 shares
|
— | 30 Jun 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.6%
|
$38,783
17,237 shares
|
— | 30 Jun 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.1%
|
$6,718
2,999 shares
|
— | 30 Jun 2024 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
0.01%
|
$345
154 shares
|
— | 30 Jun 2024 |
| Main Street Group, LTD |
13F
Company
|
0%
|
$209
100 shares
|
— | 30 Jun 2024 |
| Allworth Financial LP |
13F
Company
|
0%
|
$139
85 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
48,551
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q3 2025 Across Filers
Q3 2025 holders
13
Q3 2024 holders
8
Holder diff
-5
| Investor | Q3 2025 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q3 2025 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend